Tech Company Financing Transactions
Vaccinex Funding Round
Vaccinex closed a $25 million Series B financing round on 2/26/2008. Investors included Teva Pharmaceutical Industries and private investors.
Transaction Overview
Company Name
Announced On
2/26/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1895 Mt. Hope Ave.
Rochester, NY 14620
USA
Rochester, NY 14620
USA
Phone
Website
Email Address
Overview
Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of human monoclonal antibodies to treat a variety of serious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maurice Zauderer
Chief Operating Officer
Raymond Watkins
Chief Scientific Officer
Ernest Smith
VP - Bus. Development
John Leonard
Browse more venture capital transactions:
Prev: 2/25/2008: GeoLearning venture capital transaction
Next: 2/26/2008: FriendFeed venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs